Friday 5 October 2012

Axitinib Flops as Add-On in NSCLC Study (CME/CE)

VIENNA (MedPage Today) -- A once-promising small molecule did not improve treatment efficacy when added to standard platinum-based therapy for advanced non-small cell lung cancer, researchers reported. via MedPageToday.com - medical news plus CME for physicians Read More Here..

No comments:

Post a Comment